GHK-Cu: the copper peptide, explained
GHK-Cu is the copper tripeptide-1 — a naturally occurring human peptide that binds copper and declines with age, used for decades in skincare and, more recently, injected by the peptide community. The honest headline: its topical evidence is genuinely strong; its injectable evidence is thin. This page keeps that split explicit, plus why the solution is blue, the regulatory status (cosmetic-legal, injectable not approved), the half-life, the reconstitution math for its larger mg-scale vials, storage, and how to track it. It is not dosing or sourcing advice.
- • GHK-Cu = copper tripeptide-1, a natural human peptide that declines with age; binds and delivers copper.
- • Topical = strong evidence (wound healing, collagen/elastin, decades of cosmetic use). Injectable = thin evidence (mostly extrapolated).
- • Cosmetic-legal topically; injectable not FDA-approved; reconstituted solution is blue (copper) and stings (acidic).
- • This page is honest facts + math + tracking — not a dose protocol and not sourcing advice.
What GHK-Cu is
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK) — three amino acids (glycine, histidine, lysine) bound to a copper ion. It is a naturally occurring human peptide, first isolated from plasma in 1973, also found in saliva and urine. Its plasma level declines with age (roughly 200 ng/mL at age 20 down to ~80 ng/mL by 60), which is the usual rationale offered for its regenerative role. Its cosmetic-ingredient name is Copper Tripeptide-1.
The evidence split — topical vs injectable (read this)
This is the part to get right. The evidence for GHK-Cu is not one thing — it depends entirely on the route.
Topical / cosmetic — genuinely strong
Used in skincare for decades, with a real mechanistic and (modest) clinical base, mostly from Pickart & Margolina reviews and in-vitro/animal work: it accelerates wound healing and skin remodeling, stimulates collagen (I & III), elastin, glycosaminoglycans and decorin, modulates matrix metalloproteinases, and acts as an antioxidant and a safe copper-delivery vehicle. Cosmetic clinical studies (anti-wrinkle, firming, skin density) exist, though they are typically small and short. This is a legitimately evidenced topical ingredient.
Injectable / systemic — thin
The community claims for injected GHK-Cu (systemic tissue repair, hair regrowth, anti-inflammatory, "anti-aging") have little-to-no human clinical-trial evidence. They are largely extrapolated from the topical, in-vitro and animal data above. A 2025 study showing hair regrowth used topical copper peptides + microneedling, not systemic injection. The honest reading: the topical case is decent; the injectable case is unproven in humans.
The math
Injectable GHK-Cu ships as a lyophilized powder — and unlike most peptides, its vials are often larger (commonly 50 mg or 100 mg) because it is dosed at the milligram scale, not micrograms. The same reconstitution arithmetic the peptide reconstitution calculator does for any vial applies. Worked example, purely as arithmetic:
| Vial label | 50 mg lyophilized powder |
| Add | 5 mL bacteriostatic water |
| Concentration | 50 mg ÷ 5 mL = 10 mg/mL |
| Per 0.1 mL | 1 mg — i.e. 10 units on a U-100 syringe = 1 mg |
| So 2 mg would be | 0.2 mL = 20 units |
Concentration is just milligrams divided by millilitres, and units are just hundredths of a millilitre on a U-100 insulin syringe. The reconstituted solution will be a characteristic blue — that's the copper ion, the molecule's visual fingerprint. The reconstitution calculator converts vial size + water + target into exact syringe units. The milligrams above are illustrative arithmetic, not a recommended dose — commonly reported injectable patterns are ~1–2 mg/day, but no validated human injectable dose exists.
Half-life & the injection sting
Formal pharmacokinetic data is limited, especially for injection; the plasma half-life is reported as short — roughly 30–60 minutes (approximate, secondary-source). Two practical notes worth stating honestly: (1) injectable GHK-Cu solutions are acidic (pH ~3.5–4.5) and commonly sting or burn at the injection site, with transient redness or small lumps; (2) because plasma clearance is fast, claims of long-lasting systemic effect rest on tissue retention that isn't well characterized in humans.
Storage & handling
- Lyophilized (powder, unreconstituted): a blue powder; kept cold and away from light for long-term storage.
- Reconstituted (in bacteriostatic water): refrigerated at 2–8°C (36–46°F), not frozen; commonly used within about four weeks. The blue color is normal.
- Reconstitution technique: swab the stopper, add water slowly down the vial wall, swirl gently rather than shake.
- Quality honesty: for research-grade injectable material, purity, copper content, endotoxin and sterility are unregulated — there's no guarantee of the stated milligrams or of sterility.
Stacking — the "GLOW" blend
GHK-Cu is most often discussed alongside BPC-157 and TB-500 in skin and tissue-repair contexts — the popular "GLOW" blend is GHK-Cu + BPC-157 + TB-500. This is community practice, not clinical guidance; none of the three is FDA-approved for human therapy. In OptiPin a blend like this is tracked as separate compounds, each with its own schedule, dose log and vial inventory.
Tracking GHK-Cu in OptiPin
If you are tracking a copper-peptide protocol, OptiPin treats it like any other entry — without endorsing the injectable use:
- Dose log + reminders — record each injection (or topical application) and get reminded on the due day, with site rotation.
- Symptom & skin tracking — log the specific outcome you care about over time so a trend lines up against actual dosing.
- OptiInsight analysis — OptiPin's AI reads the full record (doses, symptoms, labs) and surfaces what moved with what.
- Vial & supply tracking — log the reconstituted vial (mg-scale); OptiPin estimates remaining volume, doses left and an empty date.
- Built-in reconstitution math — the same calculator covered above is in the app, so the mg-to-syringe-unit conversion is one tap.
Log doses, skin notes & vials in OptiPin
Reminders, outcome-over-dose charts, vial runout warnings, built-in reconstitution math, and OptiInsight analysis — all on-device.
Download on the App StoreFAQ
Is GHK-Cu approved or legal?
Topically, yes — Copper Tripeptide-1 is a legal cosmetic ingredient. As an injectable drug it is not FDA-approved (sold as a "research chemical"); its injectable compounding status is in transition with an FDA review slated before Feb 2027. Cosmetic-legal ≠ injectable-approved.
Topical vs injectable — where's the evidence?
Topical has the strong, peer-reviewed base (wound healing, collagen/elastin, decades of use). Injectable/systemic has little-to-no human trial evidence — those claims are extrapolated from lab and animal data.
Why is it blue?
The copper. GHK-Cu is the copper(II) complex of the GHK tripeptide; the bound copper ion gives the powder and reconstituted solution their blue color.
Half-life and dosing?
Limited data; plasma half-life ~30–60 min (approximate). Commonly reported: ~1–2 mg/day injected, or 1–2% topical creams. Injection commonly stings because the solution is acidic (pH ~3.5–4.5). Not a recommendation.
Is GHK-Cu banned in sport?
Not explicitly named on the 2026 WADA list, unlike GH secretagogues. But catch-all categories (S0/S2) could apply depending on form and intent, so tested athletes should be cautious. We don't assert a specific named ban.
Sources
- Pickart, Vasquez-Soltero & Margolina — "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration" (2015)
- Pickart & Margolina — "Regenerative and Protective Actions of the GHK-Cu Peptide" (Int. J. Mol. Sci., 2018)
- Copper peptide GHK-Cu — overview, chemistry, evidence caveats
- Cosmetic Ingredient Review — safety assessment of tripeptide-1 / copper-peptide cosmetic ingredients
- FDA — Bulk Drug Substances Used in Compounding Under 503A
Related
BPC-157 · TB-500 · Peptides guide · Peptide reconstitution calculator · Half-life visualizer · Injection technique